Phytochemical Name : Lanostane

Properties Information
PhytoCAT-ID PhytoCAT-810
Phytochemical name or plant extracts Lanostane
PMID 32862572
Literature evidence PURPOSE: This study was performed to investigate the effects of lanostane against human breast cancer cells with emphasis on its potential to inhibit cancer cell growth and metastasis along with understanding the underlying molecular mechanism mediating the effects.
IUPAC name (5S,8R,9S,10R,13R,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene
Phytochemicals’ class or type of plant extracts Triterpenoid
Source of phytochemicals or plant Extracts Lyonia ovalifolia
Geographical availability China North-Central, China South-Central, China Southeast
Plant parts Flowers
Other cancers Breast cancer
Target gene or protein Bax, Bcl-2
Gene or Protein evidence The antiproliferative effects of lanostane were modulated through Bax/Bcl-2 pathway inducing apoptosis of cancer cells.
Target pathways Rho-associated kinases (ROCK) signaling pathway
IC50 NA
Potency The results of the present study are suggestive of anticancer effects of lanostene triterpene which exerted its effects by inhibiting cell proliferation and metastasis of breast cancer cells mediated through inactivation of Rho-associated kinase signaling. The study holds promise to provide a lead for exploring the secondary metabolite-based anticancer approach against various human malignancies.
Cell line/ mice model SKBR-3, MB-157
Additional information  The inhibition of cell metastasis was modulated through Rho-associated kinases (ROCK) signaling pathway which is involved in metastasis of breast cancer to bone tissues. Hence, the results suggested that lanostane inhibited the breast cancer metastasis to bone.
PubChem ID 9548665
Additional PMIDs 33830612 25457485 32007721 32862572
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:77250333-1
Safety NA